Drug profile · INN
monoctanoin
MOCTANIN
monoctanoin (MOCTANIN) is a unknown. Route of administration: perfusion, biliary. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — monoctanoin
- US status
- approved
- Class
- —
- Route
- PERFUSION, BILIARY
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
monoctanoin (MOCTANIN) is a unknown. Route of administration: perfusion, biliary. Current US regulatory status: approved.
Key facts
INN monoctanoin
Brand MOCTANIN
Mechanism Unknown
Route PERFUSION, BILIARY
Formulation LIQUID
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is monoctanoin?
monoctanoin (MOCTANIN) is a unknown. Route of administration: perfusion, biliary. Current US regulatory status: approved.
What is the brand name for monoctanoin?
MOCTANIN is a marketed brand name for monoctanoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of monoctanoin?
monoctanoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.